Q3303741 (Q3303741): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: Setting new description) |
(Created claim: summary (P836): The generation of atomic-resolved 3D models of interaction between proteins and drug candidates makes a decisive contribution to the success of any drug development. In order to optimise the information content of 3D models, the applicant will optimally harmonise or synchronise the process chain from protein synthesis to 3D model using technologies for the production of premium proteins and premium crystals in the sense of 3D model generation.,...) |
||||||||||||||
| Property / summary | |||||||||||||||
The generation of atomic-resolved 3D models of interaction between proteins and drug candidates makes a decisive contribution to the success of any drug development. In order to optimise the information content of 3D models, the applicant will optimally harmonise or synchronise the process chain from protein synthesis to 3D model using technologies for the production of premium proteins and premium crystals in the sense of 3D model generation. (English) | |||||||||||||||
| Property / summary: The generation of atomic-resolved 3D models of interaction between proteins and drug candidates makes a decisive contribution to the success of any drug development. In order to optimise the information content of 3D models, the applicant will optimally harmonise or synchronise the process chain from protein synthesis to 3D model using technologies for the production of premium proteins and premium crystals in the sense of 3D model generation. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: The generation of atomic-resolved 3D models of interaction between proteins and drug candidates makes a decisive contribution to the success of any drug development. In order to optimise the information content of 3D models, the applicant will optimally harmonise or synchronise the process chain from protein synthesis to 3D model using technologies for the production of premium proteins and premium crystals in the sense of 3D model generation. (English) / qualifier | |||||||||||||||
point in time: 24 October 2021
| |||||||||||||||
Revision as of 17:35, 24 October 2021
Project Q3303741 in Germany
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q3303741 in Germany |
Statements
251,840.0 Euro
0 references
1 September 2019
0 references
31 May 2023
0 references
CrystalsFirst GmbH
0 references
36037
0 references
Die Generierung von atomaufgelösten 3D-Modellen der Interaktion von Proteinen und Arzeneistoffkandidatem trägt entrscheidendc zum Erfolg jeder Arzneistoffentwicklung bei. Um den Informationsgehalt von 3D-Modellen optimal zu gestalten, wird der Antragstellerdie Prozesskette von der Proteinsynthese bis zum 3D-Modell mittels Technologien zur Erzeugung von Premiumproteinen und Premiumkristallen optimal im Sinne der 3D-Modell-Generierung harmonisieren bzw. synchronisieren. (German)
0 references
The generation of atomic-resolved 3D models of interaction between proteins and drug candidates makes a decisive contribution to the success of any drug development. In order to optimise the information content of 3D models, the applicant will optimally harmonise or synchronise the process chain from protein synthesis to 3D model using technologies for the production of premium proteins and premium crystals in the sense of 3D model generation. (English)
24 October 2021
0 references
Identifiers
DE_TEMPORARY_6528
0 references